Global Neurovascular Devices Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Neurovascular Devices market size was valued at US$ 3288 million in 2024 and is forecast to a readjusted size of USD 4479 million by 2031 with a CAGR of 5.2% during review period.
Neurovascular devices are medical devices used to diagnose, treat, and manage various diseases affecting the blood vessels in the brain and nervous system. Neurovascular diseases typically include conditions such as stroke (both ischemic and hemorrhagic), brain aneurysms, arteriovenous malformations (AVMs), and other vascular abnormalities. These devices play a critical role in neurovascular procedures, enabling minimally invasive treatments that enhance patient outcomes.
Common neurovascular devices include stents, coils, embolization devices, flow diversion devices, microcatheters, aspiration systems, and intracranial pressure (ICP) monitors. Stents are primarily used to treat narrowed blood vessels, often in patients with cerebral aneurysms or carotid artery disease. Coils are used to embolize brain aneurysms, promoting clot formation inside the aneurysm and reducing the risk of rupture. Flow diversion devices are used to alter blood flow in the brain, typically for aneurysm treatment, to reduce the risk of rupture. Microcatheters and embolization devices are mainly used to occlude abnormal blood vessels in conditions like AVMs or tumors. Aspiration devices are employed to remove blood clots in acute ischemic strokes, restoring blood flow to the brain.
These devices have significantly advanced the treatment of neurovascular diseases, improving the precision and safety of procedures. As medical technology progresses, the role of these devices in minimally invasive surgeries continues to grow, and they will remain essential in the development of the field of neurointervention and neurosurgery.
1. Market Development Opportunities and Key Drivers:
The market for neurovascular devices is driven by several key factors:
Rising Stroke Incidence: As the global population ages, the incidence of strokes, especially ischemic strokes, continues to increase, driving demand for neurovascular devices.
Technological Advancements: With the development of minimally invasive technologies, neurovascular procedures have become more precise and safer. New devices and materials, such as flow diversion devices and automated aspiration systems, have made neurointerventional procedures more efficient and feasible.
Expanded Healthcare Coverage: The expansion of healthcare insurance systems and increasing healthcare expenditures have driven the demand for effective medical devices.
Increased Health Awareness: As public awareness of cerebrovascular diseases rises, there is a growing demand for early diagnosis and prevention, further fueling the neurovascular device market.
2. Market Risks:
High Treatment Costs: Neurovascular devices are often expensive, particularly high-end devices and treatments, which may create entry barriers in developing countries.
Technological Risks: The development of new technologies is uncertain, requiring long clinical trials and regulatory approvals. Additionally, the rapid pace of technological advancements may render products obsolete.
Regulatory and Compliance Risks: The approval process for medical devices is stringent, especially for new technologies, and regulatory challenges may hinder market adoption.
3. Market Concentration:
The neurovascular device market is relatively concentrated, with a few leading global medical device companies dominating the market. Major players include Medtronic, Stryker, Boston Scientific, and others. These companies have strong R&D capabilities and extensive distribution networks, enabling them to provide high-quality products and maintain a dominant position globally.
4. Downstream Demand Trends:
Increasing Demand Due to Aging Population: As the global population ages, the prevalence of cerebrovascular diseases such as strokes continues to rise, driving the demand for neurovascular treatments and devices.
Preference for Minimally Invasive Procedures: Patients increasingly prefer minimally invasive surgeries, which reduce hospital stays and recovery times, leading to a growing demand for minimally invasive neurovascular devices.
Customized Treatment Needs: With the advancement of precision medicine, there is an increasing demand for personalized treatment solutions, which has led to the development of tailored neurovascular devices.
5. Latest Technologies:
Flow Diversion Devices: This technology has made significant progress in treating brain aneurysms, especially in high-risk patients, by diverting blood flow away from the aneurysm to reduce the risk of rupture.
Automated Aspiration Systems: These systems are used for clot retrieval in acute ischemic stroke, enabling rapid and effective restoration of blood flow to the brain.
Minimally Invasive Surgical Systems: Recent advancements in minimally invasive surgery have made neurovascular procedures more precise, reducing surgical risks and recovery times by using smaller catheters and more accurate techniques.
This report is a detailed and comprehensive analysis for global Neurovascular Devices market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neurovascular Devices market size and forecasts, in consumption value ($ Million), 2020-2031
Global Neurovascular Devices market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Neurovascular Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Neurovascular Devices market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurovascular Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurovascular Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker Corporation, Johnson & Johnson, Medtronic, Terumo Neuro, Penumbra, Inc. (Neuro), Shanghai MicroPort Medical (Group) Co.，Ltd., Abbott Vascular, Medical Murray, Boston Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Neurovascular Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Thrombectomy Devices
Intracranial Stents
Embolization Devices
Flow Diversion Devices
Others
Market segment by Application
Stroke Treatment
Aneurysm Treatment
Cerebral Vascular Stenosis Treatment
Traumatic Brain Injury and Intracranial Hemorrhage Treatment
Others
Market segment by players, this report covers
Stryker Corporation
Johnson & Johnson
Medtronic
Terumo Neuro
Penumbra, Inc. (Neuro)
Shanghai MicroPort Medical (Group) Co.，Ltd.
Abbott Vascular
Medical Murray
Boston Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Neurovascular Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurovascular Devices, with revenue, gross margin, and global market share of Neurovascular Devices from 2020 to 2025.
Chapter 3, the Neurovascular Devices competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Neurovascular Devices market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurovascular Devices.
Chapter 13, to describe Neurovascular Devices research findings and conclusion.
Neurovascular devices are medical devices used to diagnose, treat, and manage various diseases affecting the blood vessels in the brain and nervous system. Neurovascular diseases typically include conditions such as stroke (both ischemic and hemorrhagic), brain aneurysms, arteriovenous malformations (AVMs), and other vascular abnormalities. These devices play a critical role in neurovascular procedures, enabling minimally invasive treatments that enhance patient outcomes.
Common neurovascular devices include stents, coils, embolization devices, flow diversion devices, microcatheters, aspiration systems, and intracranial pressure (ICP) monitors. Stents are primarily used to treat narrowed blood vessels, often in patients with cerebral aneurysms or carotid artery disease. Coils are used to embolize brain aneurysms, promoting clot formation inside the aneurysm and reducing the risk of rupture. Flow diversion devices are used to alter blood flow in the brain, typically for aneurysm treatment, to reduce the risk of rupture. Microcatheters and embolization devices are mainly used to occlude abnormal blood vessels in conditions like AVMs or tumors. Aspiration devices are employed to remove blood clots in acute ischemic strokes, restoring blood flow to the brain.
These devices have significantly advanced the treatment of neurovascular diseases, improving the precision and safety of procedures. As medical technology progresses, the role of these devices in minimally invasive surgeries continues to grow, and they will remain essential in the development of the field of neurointervention and neurosurgery.
1. Market Development Opportunities and Key Drivers:
The market for neurovascular devices is driven by several key factors:
Rising Stroke Incidence: As the global population ages, the incidence of strokes, especially ischemic strokes, continues to increase, driving demand for neurovascular devices.
Technological Advancements: With the development of minimally invasive technologies, neurovascular procedures have become more precise and safer. New devices and materials, such as flow diversion devices and automated aspiration systems, have made neurointerventional procedures more efficient and feasible.
Expanded Healthcare Coverage: The expansion of healthcare insurance systems and increasing healthcare expenditures have driven the demand for effective medical devices.
Increased Health Awareness: As public awareness of cerebrovascular diseases rises, there is a growing demand for early diagnosis and prevention, further fueling the neurovascular device market.
2. Market Risks:
High Treatment Costs: Neurovascular devices are often expensive, particularly high-end devices and treatments, which may create entry barriers in developing countries.
Technological Risks: The development of new technologies is uncertain, requiring long clinical trials and regulatory approvals. Additionally, the rapid pace of technological advancements may render products obsolete.
Regulatory and Compliance Risks: The approval process for medical devices is stringent, especially for new technologies, and regulatory challenges may hinder market adoption.
3. Market Concentration:
The neurovascular device market is relatively concentrated, with a few leading global medical device companies dominating the market. Major players include Medtronic, Stryker, Boston Scientific, and others. These companies have strong R&D capabilities and extensive distribution networks, enabling them to provide high-quality products and maintain a dominant position globally.
4. Downstream Demand Trends:
Increasing Demand Due to Aging Population: As the global population ages, the prevalence of cerebrovascular diseases such as strokes continues to rise, driving the demand for neurovascular treatments and devices.
Preference for Minimally Invasive Procedures: Patients increasingly prefer minimally invasive surgeries, which reduce hospital stays and recovery times, leading to a growing demand for minimally invasive neurovascular devices.
Customized Treatment Needs: With the advancement of precision medicine, there is an increasing demand for personalized treatment solutions, which has led to the development of tailored neurovascular devices.
5. Latest Technologies:
Flow Diversion Devices: This technology has made significant progress in treating brain aneurysms, especially in high-risk patients, by diverting blood flow away from the aneurysm to reduce the risk of rupture.
Automated Aspiration Systems: These systems are used for clot retrieval in acute ischemic stroke, enabling rapid and effective restoration of blood flow to the brain.
Minimally Invasive Surgical Systems: Recent advancements in minimally invasive surgery have made neurovascular procedures more precise, reducing surgical risks and recovery times by using smaller catheters and more accurate techniques.
This report is a detailed and comprehensive analysis for global Neurovascular Devices market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neurovascular Devices market size and forecasts, in consumption value ($ Million), 2020-2031
Global Neurovascular Devices market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Neurovascular Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Neurovascular Devices market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurovascular Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurovascular Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker Corporation, Johnson & Johnson, Medtronic, Terumo Neuro, Penumbra, Inc. (Neuro), Shanghai MicroPort Medical (Group) Co.，Ltd., Abbott Vascular, Medical Murray, Boston Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Neurovascular Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Thrombectomy Devices
Intracranial Stents
Embolization Devices
Flow Diversion Devices
Others
Market segment by Application
Stroke Treatment
Aneurysm Treatment
Cerebral Vascular Stenosis Treatment
Traumatic Brain Injury and Intracranial Hemorrhage Treatment
Others
Market segment by players, this report covers
Stryker Corporation
Johnson & Johnson
Medtronic
Terumo Neuro
Penumbra, Inc. (Neuro)
Shanghai MicroPort Medical (Group) Co.，Ltd.
Abbott Vascular
Medical Murray
Boston Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Neurovascular Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurovascular Devices, with revenue, gross margin, and global market share of Neurovascular Devices from 2020 to 2025.
Chapter 3, the Neurovascular Devices competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Neurovascular Devices market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurovascular Devices.
Chapter 13, to describe Neurovascular Devices research findings and conclusion.
Table of Contents
87 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
